ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 101 filers reported holding ADICET BIO INC in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $315,649 | -46.3% | 230,401 | -4.8% | 0.00% | – |
| Q2 2023 | $588,057 | -61.1% | 241,999 | -7.8% | 0.00% | – |
| Q1 2023 | $1,511,609 | -36.5% | 262,432 | -1.5% | 0.00% | – |
| Q4 2022 | $2,382,233 | -30.5% | 266,469 | +10.6% | 0.00% | -100.0% |
| Q3 2022 | $3,427,000 | +4.9% | 240,997 | +7.7% | 0.00% | 0.0% |
| Q2 2022 | $3,267,000 | -19.9% | 223,760 | +9.6% | 0.00% | 0.0% |
| Q1 2022 | $4,078,000 | +37.5% | 204,200 | +20.4% | 0.00% | – |
| Q4 2021 | $2,965,000 | +118.3% | 169,551 | -2.1% | 0.00% | – |
| Q3 2021 | $1,358,000 | -28.0% | 173,199 | -5.4% | 0.00% | – |
| Q2 2021 | $1,885,000 | +454.4% | 183,142 | +604.8% | 0.00% | – |
| Q1 2021 | $340,000 | – | 25,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |